Suppr超能文献

灰黄霉素和地衣酸磺酰胺衍生物的合成、生物和计算机研究作为真菌、细菌和人碳酸酐酶抑制剂。

Synthesis, Biological and In Silico Studies of Griseofulvin and Usnic Acid Sulfonamide Derivatives as Fungal, Bacterial and Human Carbonic Anhydrase Inhibitors.

机构信息

NeuroFarba Department, Sezione di ScienzeFarmaceutiche, Università degli Studi di Firenze, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Italy.

Istituto di Bioscienze e Biorisorse, CNR (National Research Council), Via Pietro Castellino 111, 80131 Napoli, Italy.

出版信息

Int J Mol Sci. 2023 Feb 1;24(3):2802. doi: 10.3390/ijms24032802.

Abstract

Carbonic anhydrases (CAs, EC 4.2.1.1) catalyze the essential reaction of CO hydration in all living organisms, being actively involved in the regulation of a plethora of patho-/physiological conditions. A series of griseofulvin and usnic acid sulfonamides were synthesized and tested as possible CA inhibitors. Since β- and γ- classes are expressed in microorganisms in addition to the α- class, showing substantial structural differences to the human isoforms they are also interesting as new antiinfective targets with a different mechanism of action for fighting the emerging problem of extensive drug resistance afflicting most countries worldwide. Griseofulvin and usnic acid sulfonamides were synthesized using methods of organic chemistry. Their inhibitory activity, assessed against the cytosolic human isoforms hCA I and hCA II, the transmembrane hCA IX as well as β- and γ-CAs from different bacterial and fungal strains, was evaluated by a stopped-flow CO hydrase assay. Several of the investigated derivatives showed interesting inhibition activity towards the cytosolic associate isoforms hCA I and hCA II, as well as the three γ-CAs and (MgCA) enzyme. Six compounds (-, and ) were more potent than AAZ against hCA I while five (, , , and ) showed better activity than AAZ against the hCA II isoform. Moreover, all compounds appeared to be very potent against MgCA with a Ki lower than that of the reference drug. Furthermore, computational procedures were used to investigate the binding mode of this class of compounds within the active site of human CAs.

摘要

碳酸酐酶(CAs,EC 4.2.1.1)催化所有生物中 CO 水合的基本反应,积极参与多种病理/生理条件的调节。我们合成了一系列灰黄霉素和地衣酸磺酰胺,并测试了它们作为潜在 CA 抑制剂的可能性。由于β-和γ-类在微生物中与α-类一起表达,与人类同工酶有显著的结构差异,因此它们也是新的抗感染靶点,具有不同的作用机制,可用于对抗全球大多数国家广泛存在的耐药性问题。灰黄霉素和地衣酸磺酰胺是通过有机化学方法合成的。通过停流 CO 水合酶测定法评估它们对细胞质人同工酶 hCA I 和 hCA II、跨膜 hCA IX 以及来自不同细菌和真菌株的β-和γ-CAs 的抑制活性。研究的几种衍生物对细胞质相关同工酶 hCA I 和 hCA II 以及三种γ-CAs 和 (MgCA) 酶表现出有趣的抑制活性。六种化合物(-、-和-)对 hCA I 的抑制活性强于 AAZ,而五种化合物(-、-、-、-和-)对 hCA II 同工酶的抑制活性强于 AAZ。此外,所有化合物对 MgCA 的抑制活性似乎都非常强,其 Ki 值低于参考药物。此外,还使用计算程序研究了该类化合物在人 CA 活性部位的结合模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4517/9917406/1d68e1fdaa88/ijms-24-02802-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验